Following the discovery of distinct subsets of CD4+ T-cell effectors, known as type 1 T helper (Th1) and type 2 Th (Th2), which mainly produce interferon (IFN)-γ or interleukin (IL)-4, respectively, a novel population has been discovered and named as type 17 Th (Th17) because of the its unique ability to produce IL-17A. Murine Th17 cells play a protective role against extracellular bacteria and fungi by inducing an inflammatory response characterized not only by the presence of mononuclear cells but also of neutrophil granulocytes. Murine Th17 cells have been considered as major players in the pathogenesis of murine autoimmune disorders while Th1 cells seemed to have a protective role. However, this concept has recently been challenged by the demonstration that either Th17 or Th1 cells may be pathogenic even in murine models of autoimmune disorders. Th17 cells have also been identified in human blood and inflamed tissues, but they seem to exhibit different features from murine Th17 cells. First, human Th17 are characterized by the surface expression of CCR6 and IL-23R, but also of IL-12Rβ2 and CD161. Second, human Th17 cells express T-bet in addition to retinoic acid-related orphan receptor (ROR)γt and can be induced to produce IFN-γ in addition to IL-17A in the presence of IL-12, thus suggesting a close developmental relationship with Th1 cells. Finally, while murine Th17 originate from a precursor common to Foxp3+ T regulatory (Treg) cells when IL-6 is produced in combination with TGF-β, human Th17 cells originate from CD161+CD4+ precursors, which constitutively express RORγt and IL-23R, in response to the combined activity of IL-1β and IL-23. By contrast, TGF-β does not play a direct role in human Th17 differentiation, but can only favour their expansion by inhibiting T-bet expression and the development of Th1 cells. © 2008 Elsevier Ltd. All rights reserved.

Properties and origin of human Th17 cells / S.Romagnani; E.Maggi; F.Liotta; L.Cosmi; F.Annunziato. - In: MOLECULAR IMMUNOLOGY. - ISSN 0161-5890. - STAMPA. - 47:(2009), pp. 3-7. [10.1016/j.molimm.2008.12.019]

Properties and origin of human Th17 cells.

ROMAGNANI, SERGIO;MAGGI, ENRICO;LIOTTA, FRANCESCO;COSMI, LORENZO;ANNUNZIATO, FRANCESCO
2009

Abstract

Following the discovery of distinct subsets of CD4+ T-cell effectors, known as type 1 T helper (Th1) and type 2 Th (Th2), which mainly produce interferon (IFN)-γ or interleukin (IL)-4, respectively, a novel population has been discovered and named as type 17 Th (Th17) because of the its unique ability to produce IL-17A. Murine Th17 cells play a protective role against extracellular bacteria and fungi by inducing an inflammatory response characterized not only by the presence of mononuclear cells but also of neutrophil granulocytes. Murine Th17 cells have been considered as major players in the pathogenesis of murine autoimmune disorders while Th1 cells seemed to have a protective role. However, this concept has recently been challenged by the demonstration that either Th17 or Th1 cells may be pathogenic even in murine models of autoimmune disorders. Th17 cells have also been identified in human blood and inflamed tissues, but they seem to exhibit different features from murine Th17 cells. First, human Th17 are characterized by the surface expression of CCR6 and IL-23R, but also of IL-12Rβ2 and CD161. Second, human Th17 cells express T-bet in addition to retinoic acid-related orphan receptor (ROR)γt and can be induced to produce IFN-γ in addition to IL-17A in the presence of IL-12, thus suggesting a close developmental relationship with Th1 cells. Finally, while murine Th17 originate from a precursor common to Foxp3+ T regulatory (Treg) cells when IL-6 is produced in combination with TGF-β, human Th17 cells originate from CD161+CD4+ precursors, which constitutively express RORγt and IL-23R, in response to the combined activity of IL-1β and IL-23. By contrast, TGF-β does not play a direct role in human Th17 differentiation, but can only favour their expansion by inhibiting T-bet expression and the development of Th1 cells. © 2008 Elsevier Ltd. All rights reserved.
47
3
7
S.Romagnani; E.Maggi; F.Liotta; L.Cosmi; F.Annunziato
File in questo prodotto:
File Dimensione Formato  
Romagnani Mol Immunol 2009.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: DRM non definito
Dimensione 299.43 kB
Formato Adobe PDF
299.43 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/357994
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 149
  • ???jsp.display-item.citation.isi??? 132
social impact